SCHEDULE 13G/A: Sabby Entities Disclose 4.9% Passive Stake in Bluejay Diagnostics

Sabby Management, LLC, Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz have reported a passive 4.9% beneficial ownership stake in Bluejay Diagnostics, Inc. as of December 31, 2024.

Summary

• Sabby Management, LLC, Sabby Volatility Warrant Master Fund, Ltd., and Hal Mintz collectively reported beneficial ownership of 27,587 shares of Bluejay Diagnostics, Inc. Common Stock.
• This ownership represents 4.9% of the class of Bluejay Diagnostics, Inc. Common Stock.
• The reporting persons share both voting power and dispositive power over all 27,587 shares.
• The filing is an Amendment No. 1 to a Schedule 13G, indicating a previous filing existed.
• The shares were not acquired for the purpose of changing or influencing the control of the issuer.

Sentiment

Score: 5

Explanation: A routine disclosure of passive beneficial ownership, indicating an investor's stake without implying any significant strategic or financial changes for the company. The 4.9% stake is below the 5% threshold that would typically trigger more scrutiny or potential activist interest.

Positives

• The disclosure indicates an institutional investor, Sabby Management, LLC, and its related entities hold a stake in Bluejay Diagnostics, Inc., which can be seen as a vote of confidence in the company's prospects.

Negatives

• No specific negatives are indicated in this passive beneficial ownership filing.

Risks

• The filing itself does not detail specific risks related to Bluejay Diagnostics, Inc. beyond the inherent risks of investing in public securities.

Future Outlook

This Schedule 13G filing does not contain any forward-looking statements or guidance regarding Bluejay Diagnostics, Inc.'s future performance or strategic direction. It solely reports beneficial ownership by certain entities.

Industry Context

This filing is a routine disclosure of beneficial ownership by an investment firm in a diagnostics company. It does not provide insights into broader industry trends or competitive landscape, focusing solely on the ownership structure.

Stakeholder Impact

• Shareholders: The disclosure provides transparency regarding the ownership structure of Bluejay Diagnostics, Inc., showing that Sabby entities hold a significant, albeit passive, stake.

Key Dates

Keywords

Bluejay Diagnostics, Sabby Management, Sabby Volatility Warrant Master Fund, Hal Mintz, Schedule 13G, beneficial ownership, common stock, passive investment, SEC filing